Platelet Monoamine Oxidase B Activity Did Not Predict Destructive Personality Traits or Violent Recidivism: A Prospective Study in Male Forensic Psychiatric ExamineesGustavson C.a · Wass C.b · Mansson J.-E.c · Blennow K.c · Forsman A.b · Anckarsater H.a, b · Nilsson T.b
aForensic Psychiatry, Malmö University Hospital, Lund University, Lund, bForensic Psychiatry, and cNeurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Aims: This prospective study was designed to replicate previous findings of an association between the platelet monoamine oxidase B (MAO-B) activity and factors of relevance for criminal behaviour in a well-documented clinical study population. Methods: Subjects (n = 77, aged 17–76 years, median 30 years) were recruited among consecutive perpetrators of severe interpersonal violent and/or sexual crimes referred to forensic psychiatric investigation. Participants were extensively investigated by structured psychiatric, psychological and social workups, including state-of-the-art rating instruments and official records, and with laboratory tests including venous blood sampling for determination of MAO-B activity. A subset of 36 individuals had lumbar punctures to measure cerebrospinal fluid concentrations of monoamine neurotransmitter metabolites. Results: Platelet MAO-B activity did not show any significant correlation with assessments of childhood behavioural disorders, substance abuse, or psychosocial adversity, nor with any crime-related factors, such as scores on the Life History of Aggression Scale, the Psychopathy Checklist or recidivistic violent crime. No significant correlation was found between MAO-B and any of the monoamine metabolites. Analyses in subgroups of smokers/non-smokers did not change this overall result. Conclusions: The findings of the present study did not support the use of MAO-B as a biological marker for aggression-related personality traits or as a predictor for violent recidivism among violent offenders.
© 2010 S. Karger AG, Basel
- Tuvblad C, Eley T, Lichtenstein P: The development of antisocial behaviour from childhood to adolescence: a longitudinal twin study. Eur Child Adolesc Psychiatry 2005;14:216–225.
- Virkkunen M, Eggert M, Rawlings R, Linnoila M: A prospective follow-up study of alcoholic violent offenders and fire setters. Arch Gen Psychiatry 1996;53:523–529.
- Ruchkin V, Koposov RA, Klinteberg B, Oreland L, Grigorenko EL: Platelet MAO-B, personality and psychopathology. J Abnorm Psychol 2005;114:477–482.
- Chen K, Wu HF, Shih JC: The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical. J Neurochem 1993;61:187–190.
- Zuckerman M, Kuhlman DM: Personality and risk-taking: common biosocial factors. J Pers 2000;68:999–1029.
- Oreland L: Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 2004;25:79–89.
- Revely MA, Revely AM, Clifford CA, Murray RM: Genetics of platelet MAO activity in discordant schizophrenic and normal twins. Br J Psychiatry 1983;142:560–565.
- Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G: Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals – a genetic study. J Psychiatr Res 1986;20:19–29.
- Pedersen NL, Oreland L, Reynolds C, McClearn GE: Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Res 1993;46:239–251.
- Murphy DL, Donnelly CH, Miller L, Wyatt RJ: Platelet monoamine oxidase in chronic schizophrenia: some enzyme characteristics relevant to reduced activity. Arch Gen Psychiatry 1976;33:1377–1381.
- von Knorring L, Oreland L, Winblad B: Personality traits related to monoamine oxidase activity in platelets. Psychiatry Res 1984;12:11–26.
- von Knorring AL, Bohman M, von Knorring L, Oreland L: Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 1985;72:51–58.
- von Knorring AL, Hallman J, von Knorring L, Oreland L: Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcohol 1991;26:409–416.
- Zuckerman M, Ballenger JC, Post RM: The neurobiology of some dimensions of personality. Int Rev Neurobiol 1984;25:391–436.
- Schalling D, Asberg M, Edman G, Oreland L: Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 1987;76:172–182.
af Klinteberg B, Oreland L, Hallman J, Wirsén A, Levander SE, Schalling D: Exploring the connections between platelet monoamine oxidase activity and behaviour: relationships with performance in neuropsychological tasks. Neuropsychobiology 1990– 1991;23:188–196.
- Oreland L, Damberg M, Hallman J, Garpenstrand H: Smoking only explains part of the associations between platelet monoamine oxidase activity and personality. J Neural Transm 2002;109:963–975.
Luria AR: Higher Cortical Functions in MAO, ed 2. New York, Basic Books, 1980.
- Sostek AJ, Sostek AM, Murphy DL, Martin EB, Born WS: Cord blood amine oxidase activities relate to arousal and motor functioning in human newborns. Life Sci 1981;28:2561–2568.
- Cloninger CR: Temperament and personality. Curr Opin Neurobiol 1994;4:266–283.
- Sullivan JL, Baenziger JC, Wagner DL, Rauscher FP, Nurnberger JI, Holmes JS: Platelet MAO in subtypes of alcoholism. Biol Psychiatry 1990;27:911–922.
- von Knorring L, Oreland L: Platelet MAO activity in type 1/type 2 alcoholics. Alkohol Clin Exp Res 1996;20(suppl 8):224A–230A.
- Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B: Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am J Med Genet 1993;48:209–213.
- Soloff PH, Cornelius J, Foglia J, George A, Perel JM: Platelet MAO in borderline personality disorder. Biol Psychiatry 1991;29:499–502.
- Poirier MF, Loo H: Platelet MAO activity in clinical subtypes of depression and DST suppression. Acta Psychiatr Scand 1987;75:456–463.
- Georgotas A, McCue RE, Friedman E, Hapworth WE, Kim OM, Cooper TB, Chang I, Stokes PE: Relationships of platelet MAO activity to characteristics of major depressive illness. Psychiatry Res 1986;19:247–256.
- Gottfries CG, Oreland L, Wiberg A, Winblad B: Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975;25:667–673.
- Belfrage H, Lidberg L, Oreland L: Platelet monoamine oxidase activity in mentally disordered violent offenders. Acta Psychiatr Scand 1992;85:218–221.
- Garpenstrand H, Longato-Stadler E, af Klinteberg B, Grigorenko EL, Damberg M, Oreland L, Hallman J: Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders. Eur Neuropsychopharmacol 2002;12:135–140.
- Esel E, Kose K, Turan MT, Basturk M, Sofuoglu S, Aslan SS, Yabanoglu I, Gonul AS, Yazici C: Monoamine oxidase-B activity in alcohol withdrawal of smokers: is there any relationship with aggressiveness? Alcohol Alcohol 2002;37:272–276.
- Alm PO, af Klinteberg B, Humble K, Leppert J, Sorensen S, Thorell LH, Lidberg L, Oreland L: Psychopathy, platelet MAO activity and criminality among former juvenile delinquents. Acta Psychiatr Scand 1996;94:105–111.
- Hare RD: A research scale for the assessment of psychopathy in criminal populations. Pers Indiv Differ 1980;1:111–119.
- Stalenheim EG, von Knorring L, Oreland L: Platelet monoamine oxidase activity as a biological marker in a Swedish forensic psychiatric population. Psychiatry Res 1997;69:79–87.
Schalling D, Edman G: The Karolinska Scales of Personality (KSP): An Inventory for Assessing Temperament Dimensions Associated with Vulnerability for Psychosocial Deviance – Manual. Stockholm, Department of Psychiatry, Karolinska Institute, 1993.
- Soderstrom H, Blennow K, Sjodin AK, Forsman A: New evidence for an association between the CSF HVA/5-HIAA ratio and psychopathic traits. J Neurol Neurosurg Psychiatry 2003;74:918–921.
- Soderstrom H, Forsman A: Elevated triiodothyronine in psychopathy – possible physiological mechanisms. J Neural Transm 2004;111:739–744.
- Gustavson C, Stahlberg O, Sjodin AK, Forsman A, Nilsson T, Anckarsater H: Age at onset of substance abuse: a crucial covariate of psychopathic traits and aggression in adult offenders. Psychiatry Res 2007;153:195–198.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders – Revised (DSM-IV). Washington, American Psychiatric Association, 1994 (printed in Cambridge, Cambridge University Press; Swedish translation printed in Stockholm, Pilgrim Press).
First MB, Gibbon M, Spitzer RL, Williams JB: User’s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders – Research Version 2.0 (SCID-I). New York, New York State Psychiatric Institute, Biometrics Research Department, 1996.
First MB, Gibbon M, Spitzer RL, Williams JB, Smith Benjamin L: Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, American Psychiatric Press, 1997.
- Ehlers S, Gillberg C: The epidemiology of Asperger syndrome: a total population study. J Child Psychol Psychiatry 1993;34:1327–1380.
Gillberg C, Coleman M: The Biology of the Autistic Syndromes. Clinics in Developmental Medicine No 153/4. London, MacKeith Press, 2000.
- Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885–890.
Wechsler D: Manual for the Wechsler Adult Intelligence Scale – Revised. San Antonio, Psychological Corporation, 1981.
Wechsler D: Manual WAIS-R – Swedish Version. Stockholm, Psykologiförlaget, 1996.
- Hare RD, Harpur TJ, Hakstian AR, Forth AE, Hart SD, Newman JP: The revised psychopathy checklist: reliability and factor structure. Psychol Assess 1990;2:338–341.
Hare RD: Manual for the Hare Psychopathy Checklist – Revised. Toronto, Multi-Health Systems, 1991.
Webster CD, Douglas KS, Eaves D, Hart SD: HCR-20: Assessing Risk for Violence, Version 2. Burnaby, Simon Fraser University, 1997.
- Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK: Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741–746.
- Cooke DJ, Michie C: Refining the construct of psychopathy: towards a hierarchical model. Psychol Assess 2001;13:171–188.
- Cloninger CR, Przybeck TR, Svrakic DM: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.
- Beck AT, Ward C, Mendelson M: Beck Depression Inventory (BDI). Arch Gen Psychiatry 1961;4:561–571.
Beck AT, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. San Antonio, Psychological Corporation, 1996.
Svennerholm L, Håkansson G, Månsson JE, Nilsson O: Chemical differentiation of the Gaucher subtypes; in Desnick RJ, Gatt S, Grabowsky GA (eds): Gaucher Disease: A Century of Delineation and Research. New York, Liss, 1982, pp 231–252.
- Smith PK, Krohn RI, Hermansson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1998;150:76–85.
- Fowler CJ, Tipton KF: Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase. Biochem Pharmacol 1981;30:3329–3332.
- Blennow K, Wallin A, Gottfries CG, Karlsson I, Mansson JE, Skoog I, Wikkelso C, Svennerholm L: Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age. Eur Neuropsychopharmacol 1993;3:55–61.
- Gillberg IC, Gillberg C: Asperger’s syndrome – some epidemiological considerations: a research note. J Child Psychol Psychiatry 1989;30:631–638.
- Ellis L: A theory explaining biological correlates of criminality. Eur J Criminol 2005;2:287–315.
- Lidberg L, Daderman AM: Reduced serotonin levels are predisposing to violence: a simple blood test predicts dangerous character. Lakartidningen 1997;94:3385–3388.
- Whitfield JB, Pang D, Bucholz KK, Madden PAF, Heath AC, Statham DJ, Martin NG: Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Psychol Med 2000;30:443–454.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders – Revised (DSM-III-R). Washington, American Psychiatric Association, 1987 (printed in Cambridge, Cambridge University Press; Swedish translation printed in Stockholm, Pilgrim Press, 1994).
- Lidberg L, Modin I, Oreland L, Tuck JR, Gillner A: Platelet monoamine oxidase activity and psychopathy. Psychiatry Res 1985;16:339–343.
- Buchsbaum MS, Coursey RD, Murphy DL: The biochemical high-risk paradigm: behavioural and familial correlates of low platelet monoamine oxidase activity. Science 1976;194:339–341.
Oreland L, Hallman J: The correlation between platelet MAO activity and personality: short review of findings and a discussion on possible mechanisms; in Yu PM, Tipton KF, Boulton AA (eds): Progress in Brain Research. New York, Elsevier Science, 1995, vol 106.
- Stalenheim EG: Relationships between attempted suicide, temperamental vulnerability, and violent criminality in a Swedish forensic psychiatric population. Eur Psychiatry 2001;16:386–394.
- Stalenheim EG: Long-term validity of biological markers for psychopathy and criminal recidivism: follow-up 6–8 years after forensic psychiatric investigations. Psychiatry Res 2004;121:281–291.
- Alm PO, Alm M, Humble K, Leppert J, Sorensen S, Lidberg L, Oreland L: Criminality and platelet monoamine oxidase activity in former juvenile delinquents as adults. Acta Psychiatr Scand 1994;98:41–45.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.